Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPY19L1 pseudogene 2 (DPY19L1P2, THC1072510) is a human pseudogene derived from the DPY19L1 gene family. Pseudogenes are segments of DNA that resemble functional genes but have lost their gene expression or protein-coding ability through mutations such as in-frame stop codons or frame shifts. DPY19L1P2 shares high sequence similarity with the functional gene DPY19L1 but contains mutations that disrupt its open reading frame, preventing it from encoding a functional protein[2]. Neither a functional protein product nor a biological or therapeutic role has been documented for DPY19L1 pseudogene 2[2][1][5][9]. It is classified as a processed gene relic and is not considered a therapeutic target, receptor, or enzyme. If a canonical form is required for structured data purposes, this entry should be referenced as a **pseudogene** with no established function, disease relevance, or pharmacological interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DPY19L1 pseudogene 2 (DPY19L1P2).